Skip to main content

ETF comparison

FHLC vs VHT

Both Healthcare.

Fidelity MSCI Health Care Index ETF · Vanguard Health Care Index Fund ETF Shares

Holdings overlap

Weighted by ISIN/CUSIP
95.2 %

311 positions appear in both funds. Buying equal dollars of FHLC and VHT would leave roughly 95.2% of each dollar exposed to the same underlying securities.

FHLC unmatched 4.5% Shared 95.2% VHT unmatched 4.6%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In FHLC only
23 positions
Shared
311 positions
In VHT only
87 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

79 composite / 100
Expense ratio
0.084%
Net assets
$3.54B
TTM yield
1.18%
Top-10 conc.
51.9%
VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84 composite / 100
Expense ratio
0.090%
Net assets
$21.81B
whole fund, 2 share classes
TTM yield
1.39%
Top-10 conc.
51.9%

Sub-score comparison

92
Cost
91
83
Tax efficiency
83
80
Liquidity
100
40
Concentration
40
—
Tracking quality
—
FHLC sub-score VHT

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

FHLC is 1 bps cheaper than VHT. On a $100,000 position that's about $6/yr more in fees for VHT.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs VHT.

Top shared holdings

311 shared in total
# Holding In FHLC In VHT Overlap
1 Eli Lilly & Co 13.35% 14.04% 13.35%
2 Johnson & Johnson 8.93% 8.47% 8.47%
3 AbbVie Inc 6.42% 6.09% 6.09%
4 UnitedHealth Group Inc 5.44% 5.45% 5.44%
5 Merck & Co Inc 4.66% 4.66% 4.66%
6 Thermo Fisher Scientific Inc 3.09% 2.93% 2.93%
7 Amgen Inc 3.00% 2.87% 2.87%
8 Abbott Laboratories 2.66% 2.35% 2.35%
9 Gilead Sciences Inc 2.34% 2.64% 2.34%
10 Pfizer Inc 2.06% 2.35% 2.06%
11 Bristol-Myers Squibb Co 1.93% 1.84% 1.84%
12 CVS Health Corp 1.92% 1.83% 1.83%

Only in FHLC

23 total
  • Royalty Pharma PLC 0.35%
  • Xenon Pharmaceuticals Inc 0.07%
  • CRISPR Therapeutics AG 0.06%
  • uniQure NV 0.03%
  • SELLAS Life Sciences Group Inc 0.03%
  • AtaiBeckley Inc 0.02%
  • VeraDermics Inc 0.02%
  • Damora Therapeutics Inc 0.02%
  • HeartFlow Inc 0.01%
  • Jade Biosciences Inc 0.01%

Only in VHT

87 total
  • Masimo Corp 0.13%
  • Nuvalent Inc 0.07%
  • Catalyst Pharmaceuticals Inc 0.06%
  • Summit Therapeutics Inc 0.04%
  • Select Medical Holdings Corp 0.03%
  • Avanos Medical Inc 0.02%
  • agilon health Inc 0.02%
  • Esperion Therapeutics Inc 0.01%
  • KalVista Pharmaceuticals Inc 0.01%
  • CryoPort Inc 0.01%

Percentages are holdings overlap with the named fund.

Open FHLC or VHT at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.